Sernova Biotherapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 15, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Cap	55	50	81	231	243	326
Market Cap Growth	-9.89%	-38.61%	-64.72%	-5.00%	-25.66%	480.49%
Enterprise Value	68.18	54.44	75.89	210.86	193.17	298.94
Last Close Price	0.16	0.15	0.25	0.76	0.80	1.25
PE Ratio	-	3.00	2.50	5.85	8.89	41.67
PB Ratio	-5.68	-1.99	-6.28	18.42	5.10	11.63
P/TBV Ratio	-	-	-	18.90	4.65	11.22
Debt / Equity Ratio	-0.02	-0.19	-0.04	0	0.00	0.01
Net Debt / Equity Ratio	-0.14	-0.18	0.42	-1.57	-1.04	-0.98
Net Debt / EBITDA Ratio	-0.14	-0.31	0.18	0.49	2.04	4.12
Net Debt / FCF Ratio	-0.25	-0.41	0.29	0.65	3.36	4.01
Quick Ratio	0.11	0.02	0.32	2.17	10.74	19.19
Current Ratio	0.14	0.02	0.32	2.19	10.78	19.19
Return on Equity (ROE)	68.17%	82.79%	14564.20%	-129.72%	-64.54%	-43.25%
Return on Assets (ROA)	-894.24%	-364.20%	-213.74%	-108.59%	-60.15%	-39.03%
Return on Invested Capital (ROIC)	-331.29%	-588.54%	-2662.86%	-2941.70%	-1574.39%	-508.05%
Return on Capital Employed (ROCE)	61.64%	82.27%	-239777.00%	-134.42%	-65.07%	-41.80%
Earnings Yield	-	33.33%	40.00%	17.11%	11.25%	2.40%
Buyback Yield / Dilution	-5.28%	-6.95%	-1.19%	-10.87%	-11.43%	-24.45%
Total Shareholder Return	-5.28%	-6.95%	-1.19%	-10.87%	-11.43%	-24.45%